Inventor

LEONARD JAMES N

US37 patents

⚠️ This page may combine multiple inventors who share the name “LEONARD JAMES N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LEONARD JAMES N

ARENA PHARM INC

Human orphan G protein-coupled receptors

Methods for identifying a GLP-1 secretagogue

Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Endogenous and non-endogenous versions of human G protein-coupled receptors

Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY

Methods for identifying GLP-1 secretagogues

Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual

Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretagogues

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Methods for identifying a GLP-1 secretagogue

Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues

Method of using GPR35 to identify metabolic-stabilizing compounds

Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors

Human G protein-coupled receptors

Human G protein-coupled receptors for metabolic-related disorders

JANSSEN PHARMACEUTICA NV

Immunoglobulins and uses thereof

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Immunoglobulins and uses thereof

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Immunoglobulins and uses thereof

Immunoglobulins and uses thereof

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Immunoglobulins and uses thereof

CHU ZHI-LIANG

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Methods of using GPR119 receptor to identify compounds which stimulate glucose-dependent insulinotropic peptide secretion

Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagogues

GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto

RES DEV FOUNDATION

Nucleic acid encoding a novel homeobox factor which stimulates insulin expression in pancreatic islet cells

STRANG CANCER PREVENTION CENTE

Islet-specific homeoprotein and transcriptional regulator of insulin gene expression, HOXB13

CHEN RUOPING

Human orphan G protein-coupled receptors

LEONARD JAMES N

Method of screening for compounds useful in the treatment of insulin resistance, impaired glucose tolerance or diabetes